HTB news: LEN PrEP not approved in England, potential cure in macaques, AIDS 2026 online for IAS members

1 September 2026. Related: News.

September news – August news – July news – All back issues

Recent HTB highlights

• NICE fails to approve lenacapavir for HIV PrEP: will feedback lead to the right outcome in November?

This disappointing decision was not unexpected but could perhaps be overturned with additional stakeholder feedback. There is little benefit in i-Base reporting benefits of new research unless this leads to access.

• Macaque study eradicates simian HIV (SHIV) with combination treatment in very early infection

Intriguing animal study showing a combination of bNAbs and ART prevented establishing SHIV in infant macaques,

• AIDS 2026: PrEP efficacy depends on adherence not biology – PrEP access depends on politics

Review of plenary lecture by leading researcher Raphael Landovitz on the PrEP efficacy, recent UK guidelines and the importance of politics to enable global access.

• AIDS 2026: Free open access to opening ceremony and rapporteur summaries

For the first time in many years, IAS has enabled free open access to the opening ceremony and closing sessions as live webcasts and YouTube videos. These moving and important sessions are free for everyone to be able to watch even if they were not able to be a delegate.

• AIDS 2026: The promise of bNAbs in HIV cure-related research in chronic infection

Cure-related research show bNAbs could be as important in chronic HIV as in acute infection with early ART. New biomarkers could predict responders, driven by reduced reservoir diversity rather than reservoir size.

• AIDS 2026: New HIV drugs in the ART pipeline

All reports

• All back issues

Subscribe to HTB by email to receive the latest news every 3-4 weeks.

Reports will also be posted to social media.

Twitter (X) – Bluesky – Facebook – Instagram